Abiopharma

🔍 MARTIN WILLIAM C (Executive)

Company: IMMERSION CORP (IMMR)

Report Date: 2026-04-30

Detailed Transactions and Holdings:

• Acquired 7,425 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: false | shares_owned_after: 1,399,652.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 17,872 shares of Common Stock (Direct)
  Date: 2026-04-30 | Code: A | equity_swap_involved: false | shares_owned_after: 1,417,524.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: Common stock issued to the Reporting Person in lieu of salary earned, during the three months ended April 30, 2026, less applicable withholding taxes and amounts required to be paid to the Reporting Person in cash pursuant to applicable law. The total shares of the Issuer's common stock issued to the Reporting Person was calculated by determining the salary earned by the Reporting Person during the three months ended April 30, 2026, less applicable withholding taxes and amounts required to be paid in cash to the Reporting Person pursuant to applicable law, and dividing the remainder by the closing price on April 30, 2026.
• F2: Represents the shares of Common Stock issued to the Reporting Person in lieu of a cash bonus earned during the second half of the Issuer's fiscal year ending April 30, 2026, less applicable withholding taxes and amounts required to be paid in cash to the Reporting Person pursuant to applicable law. The number of shares of the Issuer's Common Stock issued to the Reporting Person was calculated by starting with the cash bonus earned by the Reporting Person during the second half of the Issuer's fiscal year ending April 30, 2026, then subtracting the applicable withholding taxes and amounts required to be paid in cash to the Reporting Person pursuant to applicable law, and dividing the remainder by the closing price on April 30, 2026.